Fosamax May Cause Osteonecrosis

In a study conducted by the U.S Food and Drug Administration, users of Fozamax experienced a higher incidence of osteonecrosis, or ONJ, compared to users of other bisphosphonates.

Marketed by pharmaceutical giant Merck & Co., under the names of Fosamax, Actonel and Boniva, the commonly-prescribed cancer and osteprorsis drugs, known as bisphosphonates, are among the most commonly prescribed drugs, with over 22 million prescriptions dispensed last year alone.

Osteonecrosis, known as ONJ or death of the jaw bone, typically occurred after minor dental work, and those suffering from ONJ may experience severe infections, tooth loss, numbness and swelling of the gums.

Treatment for osteonecrosis may require long-term antibiotic use and potential surgical intervention to reduce or repair the damaged areas of the jaw bone. Unfortunately, ONJ is resistant to common treatments, and surgery can often worsen the condition.

Unfortunately, Fosamax® remains in the body for months or years after its use has been discontinued, so even patients who are no longer using Fosamax® may have a risk for ONJ.

To compound the problem, evidence suggests that Merck did not provide timely updates to the warnings on the labels of Fosamax.

Irwin & Boesen represents persons who have been injured by dangerous drugs such as Fozamax. Please contact us for an honest evaluation of your case.

Time Limits on Filing Suit
Every case has a statute of limitations that will apply. It varies by the type of case and the state where the case is filed. Don't wait until there is trouble or until the end of your case to get a lawyer. Your attorney would prefer to be involved every step of the way, to monitor your case, to guide you, to prevent trouble, and to assist you.

If you or a loved one has been injured by the negligence of another person or company, please contact us for an honest and fair evaluation of your case.